Target intelligence / Profile preview

Intracellular macromolecular targets of cytotoxic payload

Molecular classification
Other
01

Overview

The term Intracellular macromolecular targets of cytotoxic payload refers to a broad category of biological molecules, rather than a single specific protein, that serve as the ultimate site of action for the toxic component of a targeted therapeutic, such as an antibody-drug conjugate (ADC). These targets are typically essential for cellular integrity or proliferation; common examples include tubulin, which is targeted by antimitotic agents like auristatins and maytansinoids, and DNA or topoisomerase enzymes, which are targeted by DNA-damaging agents or camptothecin derivatives. In the context of ADC therapy, the drug is delivered to a specific cell surface antigen, internalized, and then the payload is released to interact with these intracellular macromolecules to induce cell death. Because this term describes a functional class of targets rather than a specific gene product or receptor, it is considered a descriptive category used in pharmacology to define the downstream mechanism of action of cytotoxic agents.

Other names
Cytotoxic payload targetsADC payload targetsIntracellular drug targetsEffector targets
02

Mechanism of action

Payloads exert toxicity by binding to essential intracellular structures such as tubulin (inhibiting mitosis) or DNA/topoisomerases (inducing DNA damage and apoptosis) after being released from a delivery vehicle like an antibody-drug conjugate (ADC).

03

Biological functions

Cell cycleApoptosisCell deathDNA replicationMicrotubule dynamics
04

Disease associations

Cancer
05

Safety considerations

Off-target toxicity due to premature payload releaseBystander effect toxicityDose-limiting toxicities (e.g., neutropenia, neuropathy)Systemic exposure to free payload
06

Interacting drugs

Monomethyl auristatin E (MMAE)

5 more in the full profile.

07

Biomarkers

Target antigen expression (e.g., HER2, TROP2, CD33)Intracellular payload concentrationCleavable linker efficiency

Beyond the preview

Go deeper on Intracellular macromolecular targets of cytotoxic payload.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular macromolecular targets of cytotoxic payload.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call